12 Health Care Stocks Moving In Thursday's After-Market Session

BenzingaOct 17 16:30 ET

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Thursday

MT NewswiresOct 17 09:08 ET

Travere Therapeutics Receives Swiss Regulator's Temporary Marketing Approval for Kidney Disease Treatment

MT NewswiresOct 17 07:26 ET

Express News | CSL Vifor and Travere Therapeutics Announce Swissmedic Approval of Filspari® (Sparsentan) for the Treatment of Iga Nephropathy

ReutersOct 17 02:30 ET

CSL Vifor and Travere Therapeutics Announce Swissmedic Approval of FILSPARI (Sparsentan) for the Treatment of IgA Nephropathy

PR NewswireOct 17 02:30 ET

Travere Therapeutics Initiated at Sector Outperform by Scotiabank

Dow JonesOct 16 11:02 ET · Ratings